AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

In a scathing criticism of US President Donald Trump's latest tariff threat, French President Emmanuel Macron said Europe would not be intimidated. The United States plans to reduce the number of ...

Sri Lanka’s upgraded online passport appointment system that went live early Wednesday morning has garnered over 7,500 token applications (by Wednesday), managing to beat the months-long queues and ...